Skip to main content
RISE logo

FORMAMP - Innovative Nanoformulation of Antimicrobial Peptides

The extensive use of antibiotics has led to a threatening situation where bacteria have developed resistance resulting in spread of life-threatening diseases. In FORMAMP, nanotechnology-based delivery systems together with antimicrobial peptides have been used to develop innovative drug formulations for local treatment of skin and lung infections

Aim and goal

The long-term objective of the FORMAMP project is to significantly change the treatment strategies for infectious diseases and to reduce the evolution of multi-resistant bacteria.


Antimicrobial resistance


The specific aims of the project were to develop new and innovative formulation strategies for local administration, based on the combination of nanotechnology-based delivery systems and antimicrobial peptides, for the treatment of infectious diseases caused by bacteria such as Pseudomonas aeruginosa, MRSA (Methicillin-resistant Staphylococcus aureus), and MTB (Mycobacterium tuberculosis). Clinical indications that have been addressed include skin and soft tissue infections, infections in burn wounds, and infections in the lung such as cystic fibrosis and tuberculosis. A number of these indications are associated with the formation of multispecies biofilms, drastically impairing the function of available treatments. An important objective of the FORMAMP project was therefore to develop treatment strategies that also takes into account the problems associated with biofilms for clinical indications where this is of importance.


Reduce the drastic increase of resistant bacteria

Supports the UN sustainability goals

3. Good health and well-being
Ulla Elofsson

Contact person

Ulla Elofsson

Assoc. Professor

+46 10 516 60 40

Read more about Ulla

Contact Ulla
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

* Mandatory By submitting the form, RISE will process your personal data.